WAVE LIFE SCIENCES LTD. Depreciation
WAVE LIFE SCIENCES LTD. (WVE) reported Depreciation of $1.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-07-30
- WAVE LIFE SCIENCES LTD. depreciation for the quarter ending 2026-06-30 was $858.00K, a 0.81% decline year-over-year.
- WAVE LIFE SCIENCES LTD. depreciation for the quarter ending 2026-03-31 was $841.00K, a 3.89% decline year-over-year.
- WAVE LIFE SCIENCES LTD. depreciation for the quarter ending 2025-12-31 was $844.00K, a 6.95% decline year-over-year.
- WAVE LIFE SCIENCES LTD. depreciation for the quarter ending 2025-09-30 was $856.00K, a 9.70% decline year-over-year.
- WAVE LIFE SCIENCES LTD. depreciation for fiscal 2025 was $3.44M, a 11.70% decline from fiscal 2024.
- WAVE LIFE SCIENCES LTD. depreciation for fiscal 2024 was $3.90M, a 22.08% decline from fiscal 2023.
- WAVE LIFE SCIENCES LTD. depreciation for fiscal 2023 was $5.00M, a 23.94% decline from fiscal 2022.
- WAVE LIFE SCIENCES LTD. depreciation for fiscal 2022 was $6.57M, a 12.15% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $858.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.70M 10-Q · filed 2026-07-30 | $2.54M derived: sum of 3 quarters · filed 2026-07-30 | $3.40M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $841.00K 10-Q · filed 2026-04-28 | $1.69M derived: sum of 2 quarters · filed 2026-04-28 | $2.54M derived: sum of 3 quarters · filed 2026-04-28 | $3.41M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $844.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.70M derived: sum of 2 quarters · filed 2026-02-26 | $2.56M derived: sum of 3 quarters · filed 2026-07-30 | $3.44M 10-K · filed 2026-02-26 |
| 2025-09-30 | $856.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.72M derived: sum of 2 quarters · filed 2026-07-30 | $2.60M 10-Q · filed 2025-11-10 | $3.50M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $865.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.74M 10-Q · filed 2026-07-30 | $2.65M derived: sum of 3 quarters · filed 2026-07-30 | $3.60M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $875.00K 10-Q · filed 2026-04-28 | $1.78M derived: sum of 2 quarters · filed 2026-04-28 | $2.73M derived: sum of 3 quarters · filed 2026-04-28 | $3.73M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $907.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.85M derived: sum of 2 quarters · filed 2026-02-26 | $2.85M derived: sum of 3 quarters · filed 2026-02-26 | $3.90M 10-K · filed 2026-02-26 |
| 2024-09-30 | $948.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.95M derived: sum of 2 quarters · filed 2025-11-10 | $2.99M 10-Q · filed 2025-11-10 | $4.07M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $999.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $2.04M 10-Q · filed 2025-07-30 | $3.12M derived: sum of 3 quarters · filed 2026-02-26 | $4.32M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.04M 10-Q · filed 2025-05-08 | $2.12M derived: sum of 2 quarters · filed 2026-02-26 | $3.32M derived: sum of 3 quarters · filed 2026-02-26 | $4.61M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.28M derived: sum of 2 quarters · filed 2026-02-26 | $3.57M derived: sum of 3 quarters · filed 2026-02-26 | $5.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.49M derived: sum of 2 quarters · filed 2024-11-12 | $3.92M 10-Q · filed 2024-11-12 | $5.43M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.72M 10-Q · filed 2024-08-08 | $4.23M derived: sum of 3 quarters · filed 2025-03-04 | $5.87M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $1.43M 10-Q · filed 2024-05-10 | $2.94M derived: sum of 2 quarters · filed 2025-03-04 | $4.58M derived: sum of 3 quarters · filed 2025-03-04 | $6.28M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $3.15M derived: sum of 2 quarters · filed 2025-03-04 | $4.84M derived: sum of 3 quarters · filed 2025-03-04 | $6.57M 10-K · filed 2025-03-04 |
| 2022-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.33M derived: sum of 2 quarters · filed 2023-11-09 | $5.06M 10-Q · filed 2023-11-09 | $6.84M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.42M 10-Q · filed 2023-08-03 | $5.20M derived: sum of 3 quarters · filed 2023-08-03 | $7.05M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $1.73M 10-Q · filed 2023-05-03 | $3.51M derived: sum of 2 quarters · filed 2023-05-03 | $5.36M derived: sum of 3 quarters · filed 2023-05-03 | $7.26M derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $3.63M derived: sum of 2 quarters · filed 2023-03-23 | $5.54M derived: sum of 3 quarters · filed 2023-03-23 | $7.48M 10-K · filed 2023-03-23 |
| 2021-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $3.76M derived: sum of 2 quarters · filed 2022-11-10 | $5.70M 10-Q · filed 2022-11-10 | $7.72M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $3.86M 10-Q · filed 2022-08-11 | $5.87M derived: sum of 3 quarters · filed 2022-08-11 | $7.91M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.95M 10-Q · filed 2022-05-12 | $3.96M derived: sum of 2 quarters · filed 2022-05-12 | $6.00M derived: sum of 3 quarters · filed 2022-05-12 | $8.02M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $4.05M derived: sum of 2 quarters · filed 2022-03-03 | $6.08M derived: sum of 3 quarters · filed 2022-03-03 | $8.11M 10-K · filed 2022-03-03 |
| 2020-09-30 | $2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $4.06M derived: sum of 2 quarters · filed 2021-11-10 | $6.10M 10-Q · filed 2021-11-10 | $8.10M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $4.06M 10-Q · filed 2021-08-05 | $6.07M derived: sum of 3 quarters · filed 2021-08-05 | $8.01M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $2.04M 10-Q · filed 2021-05-13 | $4.04M derived: sum of 2 quarters · filed 2021-05-13 | $5.99M derived: sum of 3 quarters · filed 2021-05-13 | $7.84M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $3.95M derived: sum of 2 quarters · filed 2021-03-04 | $5.80M derived: sum of 3 quarters · filed 2021-03-04 | $7.59M 10-K · filed 2021-03-04 |
| 2019-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $3.80M derived: sum of 2 quarters · filed 2020-11-09 | $5.58M 10-Q · filed 2020-11-09 | $7.30M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $3.64M 10-Q · filed 2020-08-10 | $5.35M derived: sum of 3 quarters · filed 2020-08-10 | $6.81M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $1.78M 10-Q · filed 2020-05-11 | $3.50M derived: sum of 2 quarters · filed 2020-05-11 | $4.96M derived: sum of 3 quarters · filed 2020-05-11 | $6.19M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $3.17M derived: sum of 2 quarters · filed 2020-03-02 | $4.41M derived: sum of 3 quarters · filed 2020-03-02 | $5.58M 10-K · filed 2020-03-02 |
| 2018-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.69M derived: sum of 2 quarters · filed 2019-11-05 | $3.87M 10-Q · filed 2019-11-05 | $4.76M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $2.41M 10-Q · filed 2019-08-06 | $3.30M derived: sum of 3 quarters · filed 2020-03-02 | $3.89M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $1.18M 10-Q · filed 2019-05-10 | $2.06M derived: sum of 2 quarters · filed 2020-03-02 | $2.66M derived: sum of 3 quarters · filed 2020-03-02 | $3.02M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $889.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.48M derived: sum of 2 quarters · filed 2020-03-02 | $1.84M derived: sum of 3 quarters · filed 2020-03-02 | $2.15M 10-K · filed 2020-03-02 |
| 2017-09-30 | $595.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $951.00K derived: sum of 2 quarters · filed 2018-11-09 | $1.27M 10-Q · filed 2018-11-09 | $1.52M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $671.00K 10-Q · filed 2018-08-09 | $930.00K derived: sum of 3 quarters · filed 2019-03-01 | $1.12M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $315.00K 10-Q · filed 2018-05-09 | $574.00K derived: sum of 2 quarters · filed 2019-03-01 | $762.00K derived: sum of 3 quarters · filed 2019-03-01 | $946.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $447.00K derived: sum of 2 quarters · filed 2019-03-01 | $631.00K derived: sum of 3 quarters · filed 2019-03-01 | $784.00K 10-K · filed 2019-03-01 |
| 2016-09-30 | $188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $372.00K derived: sum of 2 quarters · filed 2017-11-09 | $525.00K 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $184.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $337.00K 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $153.00K 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |